We are live on ! Find out more
PLSE icon

Pulse Biosciences

42 hedge funds and large institutions have $26.8M invested in Pulse Biosciences in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

113% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 8

2% more funds holding

Funds holding: 4142 (+1)

0.79% more ownership

Funds ownership: 9.1%9.9% (+0.79%)

19% less capital invested

Capital invested by funds: $33.1M → $26.8M (-$6.34M)

Holders
42
Holders Change
+1
Holders Change %
+2.44%
% of All Funds
0.91%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
17
Reduced
8
Closed
1
Calls
$1.41M
Puts
Net Calls
+$1.41M
Net Calls Change
-$367K

PLSE Hedge Fund Activity: Q2 2019 in Review

42 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2019, worth a combined $26.8M — down 19% from $33.1M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new PLSE positions and 1 closed out — a net gain of 3 holders — while 17 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $1.47M. The largest seller was Bank of New York Mellon, cutting an estimated $382K.

  • 42 institutional investors held Pulse Biosciences (PLSE) as of Q2 2019, up from 41 in Q1 2019.
  • Funds reported $26.8M of Pulse Biosciences stock for Q2 2019, down 19% quarter-over-quarter.
  • 4 funds opened new Pulse Biosciences positions in Q2 2019 and 1 closed out, a net change of +3 holders.
  • The largest Pulse Biosciences buyer in Q2 2019 was BlackRock, an estimated $1.47M added.
  • The largest Pulse Biosciences seller in Q2 2019 was Bank of New York Mellon, an estimated $382K sold.

Based on aggregated 13F filings for Q2 2019.